Crown Electrokinetics Corp. focuses on commercializing electrokinetic technology for use in the smart glass market.
Crown ElectroKinetics Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$3.88|
|52 Week High||US$2.58|
|52 Week Low||US$27.00|
|1 Month Change||28.48%|
|3 Month Change||4.87%|
|1 Year Change||-13.78%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-52.10%|
Recent News & Updates
Crown ElectroKinetics EPS misses by $3.43
Crown ElectroKinetics (CRKN): FY GAAP EPS of -$4.60 misses by $3.43.As of March 31, 2021, cash and cash equivalents were $15.3 million.Press Release
Crown ElectroKinetics (CRKN ) Investor Presentation - Slideshow
The following slide deck was published by Crown ElectroKinetics Corp. in conjunction with this event.
|CRKN||US Chemicals||US Market|
Return vs Industry: CRKN underperformed the US Chemicals industry which returned 27.4% over the past year.
Return vs Market: CRKN underperformed the US Market which returned 26.8% over the past year.
Stable Share Price: CRKN is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: CRKN's weekly volatility has decreased from 30% to 10% over the past year, but is still higher than 75% of US stocks.
About the Company
Crown Electrokinetics Corp. focuses on commercializing electrokinetic technology for use in the smart glass market. The company offers electrokinetic film technology for smart or dynamic glass. It develops and sells optical switching films.
Crown ElectroKinetics Fundamentals Summary
|CRKN fundamental statistics|
Is CRKN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CRKN income statement (TTM)|
|Cost of Revenue||US$0|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-2.37|
|Net Profit Margin||0.00%|
How did CRKN perform over the long term?See historical performance and comparison
Is Crown ElectroKinetics undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate CRKN's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate CRKN's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: CRKN is unprofitable, so we can't compare its PE Ratio to the US Chemicals industry average.
PE vs Market: CRKN is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CRKN's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CRKN is overvalued based on its PB Ratio (4.2x) compared to the US Chemicals industry average (2.8x).
How is Crown ElectroKinetics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRKN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: CRKN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CRKN's is expected to become profitable in the next 3 years.
Revenue vs Market: CRKN's revenue (99% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: CRKN's revenue (99% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CRKN's Return on Equity is forecast to be high in 3 years time
How has Crown ElectroKinetics performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CRKN is currently unprofitable.
Growing Profit Margin: CRKN is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CRKN is unprofitable, and losses have increased over the past 5 years at a rate of 75.5% per year.
Accelerating Growth: Unable to compare CRKN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CRKN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (30.9%).
Return on Equity
High ROE: CRKN has a negative Return on Equity (-259.08%), as it is currently unprofitable.
How is Crown ElectroKinetics's financial position?
Financial Position Analysis
Short Term Liabilities: CRKN's short term assets ($12.7M) exceed its short term liabilities ($864.0K).
Long Term Liabilities: CRKN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CRKN's debt to equity ratio (3.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if CRKN's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRKN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CRKN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 75.9% each year
What is Crown ElectroKinetics's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CRKN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CRKN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CRKN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CRKN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CRKN's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Doug Croxall (52 yo)
Mr. Douglas B. Croxall, also known as Doug, is Chairman of the Board and Chief Executive Officer at Crown ElectroKinetics Corp. He serves as Director at Crown ElectroKinetics Corp. since 2015. Prior to co-...
CEO Compensation Analysis
Compensation vs Market: Doug's total compensation ($USD12.90M) is above average for companies of similar size in the US market ($USD542.66K).
Compensation vs Earnings: Doug's compensation has increased whilst the company is unprofitable.
Experienced Management: CRKN's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Experienced Board: CRKN's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 57.5%.
Crown ElectroKinetics Corp.'s employee growth, exchange listings and data sources
- Name: Crown ElectroKinetics Corp.
- Ticker: CRKN
- Exchange: NasdaqCM
- Founded: 2015
- Industry: Commodity Chemicals
- Sector: Materials
- Market Cap: US$59.548m
- Shares outstanding: 15.04m
- Website: https://www.crownek.com
Number of Employees
- Crown ElectroKinetics Corp.
- 1110 NE Circle Boulevard
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/15 23:34|
|End of Day Share Price||2021/10/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.